Knockdown of TMCO1 expression significantly inhibited the proliferation ability of prostatic cancer cells, Moreover, the knockdown also mitigated the proliferative impact induced by the CALR recombinant protein (Figure 3f–h). This evidence concerns the gene CALR and prostate carcinoma.